BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23501106)

  • 41. USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein.
    Ali A; Raja R; Farooqui SR; Ahmad S; Banerjea AC
    Biochem J; 2017 May; 474(10):1653-1668. PubMed ID: 28280111
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV-1 Tat second exon limits the extent of Tat-mediated modulation of interferon-stimulated genes in antigen presenting cells.
    Kukkonen S; Martinez-Viedma Mdel P; Kim N; Manrique M; Aldovini A
    Retrovirology; 2014 Apr; 11():30. PubMed ID: 24742347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phospholipid scramblase 1 potentiates the antiviral activity of interferon.
    Dong B; Zhou Q; Zhao J; Zhou A; Harty RN; Bose S; Banerjee A; Slee R; Guenther J; Williams BR; Wiedmer T; Sims PJ; Silverman RH
    J Virol; 2004 Sep; 78(17):8983-93. PubMed ID: 15308695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STAT3 Cooperates With Phospholipid Scramblase 2 to Suppress Type I Interferon Response.
    Tsai MH; Lee CK
    Front Immunol; 2018; 9():1886. PubMed ID: 30158934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV Tat protein: Is Tat-C much trickier than Tat-B?
    Johri MK; Sharma N; Singh SK
    J Med Virol; 2015 Aug; 87(8):1334-43. PubMed ID: 25879536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of HIV-1 Tat-Associated Proteins Contributing to HIV-1 Transcription and Latency.
    Jean MJ; Power D; Kong W; Huang H; Santoso N; Zhu J
    Viruses; 2017 Apr; 9(4):. PubMed ID: 28368303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Y44A Mutation in the Acidic Domain of HIV-2 Tat Impairs Viral Reverse Transcription and LTR-Transactivation.
    Szojka Z; Mótyán JA; Miczi M; Mahdi M; Tőzsér J
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824587
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Curcumin inhibits HIV-1 by promoting Tat protein degradation.
    Ali A; Banerjea AC
    Sci Rep; 2016 Jun; 6():27539. PubMed ID: 27283735
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phospholipid scramblase 1 functionally interacts with angiogenin and regulates angiogenin-enhanced rRNA transcription.
    Zhu J; Sheng J; Dong H; Kang L; Ang J; Xu Z
    Cell Physiol Biochem; 2013; 32(6):1695-706. PubMed ID: 24356419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thioredoxin reductase-1 negatively regulates HIV-1 transactivating protein Tat-dependent transcription in human macrophages.
    Kalantari P; Narayan V; Natarajan SK; Muralidhar K; Gandhi UH; Vunta H; Henderson AJ; Prabhu KS
    J Biol Chem; 2008 Nov; 283(48):33183-90. PubMed ID: 18835810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular mechanisms in the dramatic enhancement of HIV-1 Tat transduction by cationic liposomes.
    Li GH; Li W; Mumper RJ; Nath A
    FASEB J; 2012 Jul; 26(7):2824-34. PubMed ID: 22447980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.
    Rahimian P; He JJ
    J Neurovirol; 2016 Dec; 22(6):774-788. PubMed ID: 27173397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The protein arginine methyltransferase PRMT6 inhibits HIV-1 Tat nucleolar retention.
    Fulcher AJ; Sivakumaran H; Jin H; Rawle DJ; Harrich D; Jans DA
    Biochim Biophys Acta; 2016 Feb; 1863(2):254-62. PubMed ID: 26611710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PKM2-mediated inhibition of autophagy facilitates Tat's inducing HIV-1 transactivation.
    Zhang HS; Zhang ZG; Zhou Z; Du GY; Li H; Yu XY; Huang YH
    Arch Biochem Biophys; 2017 Jul; 625-626():17-23. PubMed ID: 28583828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tat acetylation regulates its actions on microtubule dynamics and apoptosis in T lymphocytes.
    Huo L; Li D; Sun L; Liu M; Shi X; Sun X; Li J; Dong B; Dong X; Zhou J
    J Pathol; 2011 Jan; 223(1):28-36. PubMed ID: 20821734
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tat is a multifunctional viral protein that modulates cellular gene expression and functions.
    Clark E; Nava B; Caputi M
    Oncotarget; 2017 Apr; 8(16):27569-27581. PubMed ID: 28187438
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6.
    Sivakumaran H; Lin MH; Apolloni A; Cutillas V; Jin H; Li D; Wei T; Harrich D
    Virol J; 2013 Jun; 10():207. PubMed ID: 23800116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.
    Zhao X; Qian L; Zhou D; Qi D; Liu C; Kong X
    Virol Sin; 2016 Jun; 31(3):199-206. PubMed ID: 27007880
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Micro-RNA: new players in HIV-pathogenesis, diagnosis, prognosis and antiviral therapy.
    Fowler L; Saksena NK
    AIDS Rev; 2013; 15(1):3-14. PubMed ID: 23449224
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HIV-1 Transcriptional Activator Tat Inhibits
    Anastasopoulou S; Georgakopoulos T; Mouzaki A
    Biomolecules; 2023 May; 13(6):. PubMed ID: 37371461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.